Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease

Neuropsychobiology

Volumn 37, Issue 1, 1997, Pages 10-19

  Stein, Dan J ^a   Buchsbaum, Monte S ^b   Hof, Patrick R ^b   Siegel Jr , Benjamin V ^c   Shihabuddin, Lina ^a,c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brodmann cortical areas; Dementia; Deoxyglucose; Neurofibrillary tangles; Positron emission tomography

Indexed keywords

GLUCOSE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; MALE; METABOLIC RATE; MOTOR CORTEX; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSORY CORTEX; STATISTICAL ANALYSIS; TEMPORAL LOBE;

EID: 0030831701     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026471     Document Type: Article

References (57)

1. Bouras C, Hof PR, Morrison JH: Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 1993;153:131-135.
2. Hyman BT, Van Hoesen GW, Damasio AR, Barnes BL: Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
3. Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, Bouras C: A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res 1987;416: 331-336.
4. Tierney MC, Fisher RW, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P: The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
5. Hof PR, Cox K, Morrison JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. 1. Superior frontal and inferior temporal cortex. J Comp Neurol 1990;301:44-54.
6. Hof PR, Morrison JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. 2. Primary and secondary visual cortex. J Comp Neurol 1990;301:55-64.
7. Hof PR, Morrison JH: The cellular basis of cortical disconnection in Alzheimer's disease and related dementing conditions; in Terry RD, Katzman R, Bick KL (eds): Alzheimer Disease. New York, Raven Press, 1994.
8. Lewis DA, Campbell MJ, Terry RD, Morrison JH: Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci 1987;7:1799-1808.
9. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
10. Rogers J, Morrison JH: Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 1985;5:2801-2808.
11. Arnold SE, Hyman BT, Flory J, Damasio R, Van Hoesen GW: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116.
12. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983;40: 711-714.
13. Buchsbaum MS, Kesslak P, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW: Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Arch Gen Psychiatry 1991;48:840-847.
14. Celsis P, Agniel A, Puel M, Rascol A, Marc-Vergnes J-P: Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1987;50:1602-1612.
15. DeCarli P, Atack JR, Ball MJ, Kay JA, Grady CL, Fewster P, Pettigrew KD, Rapoport SI, Schapiro MB: Postmortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1992;1: 113-121.
16. De Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodie J, Kricheff II, Wolf AP: Positron emission tomographic studies of aging and Alzheimer disease. Am J Neuroradiol 1983;4:568-571.
17. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI: Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
18. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G: Alzheimer's disease: Focal changes shown by positron emission tomography. Neurology 1983;33:961-965.
19. Friedland RP, Budinger TF, Koss E, Ober BA, Huesman RH, Derenzo SE: Alzheimer's disease: Antero-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985;53:235-240.
20. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI: Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 1985;5:193-200.
21. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI: Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch Neurol 1986;43:882-885.
22. Jagust WJ, Budinger TF, Reed BR: The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44: 258-262.
23. Jagust WJ, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, Budinger TF: The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res 1993;629:189-198.
24. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B: Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 1988;38:909-912.
25. Jobst KA, Smith AD, Barker CS, Wear A, King EM, Smith A, Anslow PA, Molyneux AJ, Shepstone BJ, Soper N, Holmes KA, Robinson JR, Hope RA, Oppenheimer C, Brockbank K, McDonald B: Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-194.
26. Johnson KA, Holman BL, Mueller SP, Rosen TJ, English R, Nagel JS, Growdon JH: Single photon emission computed tomography in Alzheimer's disease. Arch Neurol 1988;45:392-396.
27. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI: High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991;4:35-46.
28. McGeer PL, Kamo H, Harrop R, Li DKB, Tuokko H, McGeer EG, Adam MJ, Ammann W: Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Neurology 1986;36:879-887.
29. McGeer EG, Peppard RP, McGeer PL, Tuokko H, Crockett D, Parks R, Akiyama H, Calne DB, Beattie BL, Harrop R: 18-Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases including 13 serial scans. Can J Neurol Sci 1990;17:1-11.
30. 11C-2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab 1987;7:248-251.
31. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672-678.
32. Pearlson G, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, Noga JT, Tune LE: Quantitative changes in mesial temporal volume, regional cerebal blood flow and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-408.
33. Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC: Cerebral glucose metabolic patterns in Alzheimer's disease. Arch Gen Psychiatry 1989; 46:527-532.
34. Tamminga CA, Foster NL, Fedio P, Bird ED, Chase TN: Alzheimer's disease: Low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology 1987;37:161-165.
35. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini GP, Salerno JA, Heston LL, Rapoport SI, Horwitz B: Early detection of Alzheimer's disease: A statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 1993;13:438-447.
36. Heiss WD, Szelies B, Kessler J, Herholz K: Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann NY Acad Sci 1991;640:65-71.
37. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD: Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 1994;5:36-41.
38. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD: HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994;21:1052-1060.
39. Greitz T, Bohm C, Holte S, Eriksson L: A computerized brain atlas: Construction, anatomical content and some applications. J Comput Assist Tomogr 1991;15:26-38.
40. Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behaviour. Brain 1995;118:279-306.
41. Perry RH, Oakley AE, Perry EK: Coronal brain map and dissection guide: Localization of Brodmann areas in coronal sections.
42. Valladares-Neto DC, Buchsbaum MS, Starr A, Guich S, Rice D: EEG delta positron emission tomography and memory deficit in Alzheimer's disease. Neuropsychobiology 1995;31: 173-181.
43. Folstein MF, Folstein SE, McHugh PR: MiniMental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
44. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R: Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients. Biol Psychiatry 1987;22:479-494.
45. 14C]deoxyglucose method for measurement of local cerebral glucose utilization: Theory procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
46. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxyglucose: Validation of method. Ann Neurol 1979;6:371-388.
47. Matsui T, Hirano A: An Atlas of the Human Brain for Computerized Tomography. Tokyo, Igaku-Shoin, 1978.
48. Dixon WJ: BMDP Statistical Software. Berkeley, University of California Press, 1981.
49. Braak H, Braak E: On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol (Berl) 1985; 68:325-332.
50. Braak H, Braak E: Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol (Berl) 1991;81:261-268.
51. Van Hoesen GW, Damasio AR: Neural correlates of cognitive impairment in Alzheimer's disease; in Mountcastle VB, Plum F, Geiger SR (eds): Handbook of Physiology. The Nervous System. Bethesda, American Physiological Society, 1987, vol 5: Higher Functions of the Brain, pp 871-898.
52. De Lacoste MC, White CL III: The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system. Neurobiol Aging 1993;14:1-16.
53. Squire LR: Memory: Neuronal organization and behavior; in Mountcastle VB, Plum F, Geiger SR (eds): Handbook of Physiology. The Nervous System. Bethesda, American Physiological Society, 1987, vol 5: Higher Functions of the Brain, part 1, pp 295-371.
54. Goldman-Rakic PS: Circuitry of primate prefrontal cortex and regulation of behavior by representational memory; in Mountcastle VB, Plum F, Geiger SR (eds): Handbook of Physiology: The Nervous System. Bethesda, American Physiological Society, 1987, vol 5: Higher Functions of the Brain, part 1, pp 373-417.
55. Smith GS, DeLeon MJ, George AE, Kluger A, Volkow N, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J, Regina ME: Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Arch Neurol 1992;49:1142-1150.
56. Alavi A, Newberg AB, Souder E, Berlin JA: Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;34:1681-1687.
57. Kessler J, Herholz K, Ground M, Heiss W-D: Impaired metabolic activation in Alzheimer's disease: A PET study during continuous visual recognition. Neuropsychologia 1991;29:229-243.